RxDoctor Payments Data

Andrew Smith, MD

Neurology · Fort Collins, CONPI 1053600072

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $31,426 of the $34,859 with a category attached, or 90.2%. Sanofi accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $9,746 and has fallen 99.4% since, to $59 in 2025.

$34,859in general payments, 2019–2025

Across 28 payments — averaging $1244.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$35K
  • TG Therapeutics, Inc.$59
  • E.r. Squibb & Sons, L.L.C.$19
$109,825in research payments, 2019–2025

Across 17 payments — averaging $6460.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi$63K
  • Novartis$31K
  • EMD Serono, Inc.$15K

What the payments were for

  • Speaking & faculty fees$31,42690%
  • Travel & lodging$2,4327%
  • Food & beverage$9823%
  • Education$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi26$34,780
TG Therapeutics, Inc.1$59
E.r. Squibb & Sons, L.L.C.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,859 in reported general payments places this provider in the 85th percentile of 334 neurology providers in Colorado.

See all neurology providers in Colorado

Medicare billing

Part B allowed, 2024
$51,745
Medicare patients
302
Services billed
673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GilenyaFingolimod Hcl15$149,044
Avonex Pen (4 Pack)Interferon Beta-1a14$113,411
Kesimpta PenOfatumumab11$110,642
FingolimodFingolimod Hcl51$72,570
Dalfampridine ErDalfampridine71$24,433
Glatiramer Acetate12$10,592
Teriflunomide19$4,620
Baclofen164$4,503
Dimethyl Fumarate28$4,003
Gabapentin189$3,503
Acetazolamide17$3,122
Oxcarbazepine15$1,918
Pregabalin35$1,377
Tizanidine Hcl61$1,024
Levetiracetam25$809

Paid to pharmacies, not to this prescriber.

Other neurology in Fort Collins

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →